Novo Nordisk’s chief executive is preparing for a showdown next week with progressive firebrand Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into ...
Although limited by low statistical power, the evidence supports the use of LABAs plus ICS in a single inhaler device (to increase adherence and reduce the potential use of LABA monotherapy) for all ...